TNSN05231A1 - Enduit a ongles antifongique et procede d'utilisation - Google Patents

Enduit a ongles antifongique et procede d'utilisation

Info

Publication number
TNSN05231A1
TNSN05231A1 TNP2005000231A TNSN05231A TNSN05231A1 TN SN05231 A1 TNSN05231 A1 TN SN05231A1 TN P2005000231 A TNP2005000231 A TN P2005000231A TN SN05231 A TNSN05231 A TN SN05231A TN SN05231 A1 TNSN05231 A1 TN SN05231A1
Authority
TN
Tunisia
Prior art keywords
fungicidal
composition
coat
amount
antifungal
Prior art date
Application number
TNP2005000231A
Other languages
English (en)
Inventor
Stanley W Kepka
Mingqi Lu
Y Joseph Mo
William R Pfister
Hang-Yong Wang
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of TNSN05231A1 publication Critical patent/TNSN05231A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y10S424/808—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention concerne une composition d'enduit à ongles antifongique à double effet et un procédé d'utilisation afin d'améliorer ou d'empêcher une infection fongique des ongles et en particulier onychomycose. L'invention concerne en outre des compositions de type monocouche et double couche convenables pour des applications quotidiennes fongicides. Une composition d'enduit à ongles antifongique préférée contient une quantité efficace de fongicide, une quantité d'un promoteur de perméation sensiblement non volatil, une quantité d'un polymère hydrophile, formant une couche, et un support volatile pharmaceutiquement acceptable. Cette composition fournit un enduit fongicide sensiblement soluble dans l'eau après mise en contact avec une ongle susceptible d'infection fongiques ou ayant une infection fongique.
TNP2005000231A 2003-03-21 2005-09-19 Enduit a ongles antifongique et procede d'utilisation TNSN05231A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45668403P 2003-03-21 2003-03-21
PCT/US2004/008618 WO2004084826A2 (fr) 2003-03-21 2004-03-22 Enduit a ongles antifongique et procede d'utilisation

Publications (1)

Publication Number Publication Date
TNSN05231A1 true TNSN05231A1 (fr) 2007-06-11

Family

ID=33098141

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000231A TNSN05231A1 (fr) 2003-03-21 2005-09-19 Enduit a ongles antifongique et procede d'utilisation

Country Status (28)

Country Link
US (3) US7462362B2 (fr)
EP (2) EP1635770B1 (fr)
JP (1) JP4540667B2 (fr)
KR (1) KR101093990B1 (fr)
CN (2) CN1791378A (fr)
AT (2) ATE512672T1 (fr)
AU (1) AU2004224326B2 (fr)
BR (1) BRPI0408613A (fr)
CA (1) CA2519705C (fr)
CO (1) CO5640092A2 (fr)
CY (1) CY1111773T1 (fr)
DE (1) DE602004021253D1 (fr)
DK (2) DK1635770T3 (fr)
EC (1) ECSP056110A (fr)
ES (1) ES2366273T3 (fr)
HR (1) HRP20050918A2 (fr)
IL (1) IL170963A (fr)
IS (1) IS8078A (fr)
MA (1) MA27760A1 (fr)
MX (1) MXPA05010114A (fr)
NO (1) NO335895B1 (fr)
NZ (1) NZ542904A (fr)
PL (1) PL2106805T3 (fr)
RU (1) RU2358718C2 (fr)
SG (1) SG152065A1 (fr)
TN (1) TNSN05231A1 (fr)
WO (1) WO2004084826A2 (fr)
ZA (1) ZA200507972B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
CN101115475A (zh) * 2004-12-10 2008-01-30 塔利马治疗公司 用于治疗指甲单位病症的组合物和方法
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
EP1698336A1 (fr) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Compositions antifongiques comprenant le sertaconazole ainsi que l' hydrocortisone ou un agent antibactérien
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
US20080299060A1 (en) * 2006-01-02 2008-12-04 Tlt Medical Ltd. Pharmaceutical Composition for the Treatment of Nail Diseases
WO2007098591A2 (fr) * 2006-03-02 2007-09-07 Nuvo Research Inc. Formulation topique pour les ongles
CA2645070C (fr) 2006-03-08 2014-02-04 Nihon Nohyaku Co., Ltd. Composition pharmaceutique pour usage externe
WO2007102243A1 (fr) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. Composition pharmaceutique externe
RU2419429C2 (ru) 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
EP2191827B1 (fr) 2007-09-05 2013-10-30 Pola Pharma Inc. Composition antifongique
JP5529539B2 (ja) 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
EP2343978A4 (fr) 2008-10-03 2013-11-27 Nexmed Holdings Inc Composition stabilisée pour traiter le psoriasis
CN102256602A (zh) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 用于治疗上皮组织的组合物
WO2010047288A1 (fr) 2008-10-24 2010-04-29 Semiconductor Energy Laboratory Co., Ltd. Procédé de fabrication d’un dispositif semi-conducteur
BR122021011394B1 (pt) * 2008-12-04 2021-09-28 Chongxi Yu Composição de alta penetração de um fármaco principal, e uso de uma hpc
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
WO2010086732A1 (fr) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Compositions stables destinées au traitement des ongles et de la peau
EP2391344B1 (fr) * 2009-01-30 2017-07-12 Yissum Research Development Company of the Hebrew University of Jerusalem Compositions pour le traitement des ongles et de la peau
EP2416757A2 (fr) 2009-04-09 2012-02-15 Pola Pharma Inc. Composition pharmaceutique antimycotique
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
WO2011014850A2 (fr) 2009-07-31 2011-02-03 Nuvo Research Inc. Formulations à usage topique à base d'un eutectique
US12544491B2 (en) 2009-08-24 2026-02-10 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
WO2011024620A1 (fr) 2009-08-25 2011-03-03 Pola Pharma Inc. Composition pharmaceutique antimycotique
WO2011052224A1 (fr) * 2009-11-02 2011-05-05 株式会社福元技研 Composition cosmétique pour la peau malaxée et son procédé de production, et méthode d'utilisation de la composition cosmétique pour la peau malaxée
WO2011079234A2 (fr) 2009-12-23 2011-06-30 Nuvo Research Inc. Formulation de terbinafine à grande perméation
AU2011249040B2 (en) * 2010-05-04 2014-05-15 Nexmed Holdings, Inc. Therapeutic peptide composition and method
JP5864543B2 (ja) 2010-05-04 2016-02-17 ネクスメッド ホールディングス，インコーポレイテッド 小分子治療剤の組成物
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
RU2432158C1 (ru) * 2010-07-28 2011-10-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Профилактический бактерицидный лак для обработки ногтей
NZ609826A (en) * 2010-12-02 2016-03-31 Nexmed Holdings Inc Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
RU2013144975A (ru) * 2011-04-08 2015-05-20 Пфайзер Инк. Кристаллические и некристаллические формы тофацитиниба и фармацевтическая композиция, содержащая тофацитиниб, и усилитель проникновения
WO2012154740A1 (fr) * 2011-05-11 2012-11-15 Pellexa Research, Llc Compositions antifongiques pour le traitement de la peau et des ongles
CA2745320A1 (fr) 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Dispositif de reconstitution
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
WO2013122637A1 (fr) * 2012-02-17 2013-08-22 Capriotti Joseph Compositions antifongiques destinées au traitement de la peau et des ongles
CA2775393C (fr) * 2012-05-02 2014-04-29 Samy Saad Formulations pharmaceutiques topiques non aqueuses
EP2889031A4 (fr) * 2012-07-30 2016-01-06 Meiji Seika Pharma Co Ltd Solution anti-trichophytique à usage externe
TW201410273A (zh) 2012-07-30 2014-03-16 Meiji Seika Pharma Co Ltd 抗白癬菌症貼附劑
US8900625B2 (en) * 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
CN105377355A (zh) 2013-03-14 2016-03-02 拇趾公司 治疗甲单元的感染、疾病或病症的方法
US20140271529A1 (en) * 2013-03-14 2014-09-18 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
AU2014329421B2 (en) 2013-10-03 2018-08-02 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
JP6611014B2 (ja) 2013-11-22 2019-11-27 ボシュ ヘルス アイルランド リミテッド 抗感染方法、抗感染組成物、および抗感染装置
EP2952208A1 (fr) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Système hydroalcoolique de traitement des ongles
AR101510A1 (es) 2014-08-13 2016-12-21 Meiji Seika Pharma Co Ltd Agentes anti-trichophyton cristalinos y proceso de preparación de los mismos
MX2017009450A (es) 2015-01-20 2018-01-18 Veloce Biopharma Llc Composicion yodofora novedosa y metodos de uso.
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1410A (en) 1979-08-22 1988-04-22 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3045914A1 (de) 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
US4406509A (en) * 1981-11-25 1983-09-27 E. I. Du Pont De Nemours & Co. Jack and plug electrical assembly
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4861764A (en) 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
US5082866A (en) 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
CN1133465C (zh) * 1993-10-07 2004-01-07 奥当特克斯公司 局部用药配方的吸收增强剂
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
RU2141854C1 (ru) * 1998-11-25 1999-11-27 Закрытое акционерное общество "Интермед" Способ лечения грибковых заболеваний ногтей
US6118020A (en) 1999-05-19 2000-09-12 Nexmed Holdings, Inc. Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
AU2001243189B2 (en) * 2000-02-16 2005-06-09 Cpex Pharmaceuticals, Inc. Pharmaceutical composition
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
AU2000255769A1 (en) * 2000-07-01 2002-01-14 Chemtech Research Incorporation Process for preparation of terbinafine and its hydrochloride as an antifungal agent
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) * 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails

Also Published As

Publication number Publication date
ATE432087T1 (de) 2009-06-15
KR20060003868A (ko) 2006-01-11
NO20054830L (no) 2005-12-16
NZ542904A (en) 2009-04-30
US20060067898A1 (en) 2006-03-30
WO2004084826A3 (fr) 2004-11-04
RU2005132390A (ru) 2006-06-27
US7462362B2 (en) 2008-12-09
MXPA05010114A (es) 2006-04-27
DK2106805T3 (da) 2011-08-15
AU2004224326A1 (en) 2004-10-07
ECSP056110A (es) 2006-03-01
CY1111773T1 (el) 2015-10-07
EP1635770A2 (fr) 2006-03-22
JP2006520800A (ja) 2006-09-14
EP1635770A4 (fr) 2007-12-26
IS8078A (is) 2005-10-18
NO20054830D0 (no) 2005-10-19
CA2519705A1 (fr) 2004-10-07
CO5640092A2 (es) 2006-05-31
SG152065A1 (en) 2009-05-29
IL170963A (en) 2010-12-30
US20090099266A1 (en) 2009-04-16
DE602004021253D1 (de) 2009-07-09
CN102973420A (zh) 2013-03-20
CA2519705C (fr) 2013-07-02
EP1635770B1 (fr) 2009-05-27
US20130323189A1 (en) 2013-12-05
CN1791378A (zh) 2006-06-21
HRP20050918A2 (en) 2006-12-31
EP2106805A1 (fr) 2009-10-07
DK1635770T3 (da) 2009-08-03
EP2106805B1 (fr) 2011-06-15
PL2106805T3 (pl) 2011-10-31
RU2358718C2 (ru) 2009-06-20
JP4540667B2 (ja) 2010-09-08
ES2366273T3 (es) 2011-10-18
BRPI0408613A (pt) 2006-03-07
AU2004224326B2 (en) 2010-04-22
KR101093990B1 (ko) 2011-12-16
MA27760A1 (fr) 2006-02-01
WO2004084826A2 (fr) 2004-10-07
ATE512672T1 (de) 2011-07-15
NO335895B1 (no) 2015-03-16
ZA200507972B (en) 2007-02-28

Similar Documents

Publication Publication Date Title
TNSN05231A1 (fr) Enduit a ongles antifongique et procede d'utilisation
EP0983037A4 (fr) Vernis a ongles antifongique et son procede d'utilisation
WO2002074276A3 (fr) Compositions et kits pour soins dentaires
ATE215350T1 (de) Eine wässrige polymerdispersion enthaltender nagellack
BR0206885A (pt) Revestimentos de polìmeros de flúor coalescentes a baixas temperaturas
EP1059308A4 (fr) Polymere et composition solidifiable
AU2003285389A1 (en) Nail varnish composition comprising a sequenced polymer
DE60326966D1 (de) Selbstvernetzbare wässrige beschichtungszusammensetzung
BR0005084B1 (pt) composições cosméticas, processo de tratamento das matérias queratìnicas e utilização de um co-polìmero siliconado.
TR199802443T2 (xx) Ah�ap koruyucular�.
EP1152014A4 (fr) Composition de resine
WO2007094999A3 (fr) Compositions antifongiques pour les ongles
EP1104670A4 (fr) Preparation de compresse
EP1558266A4 (fr) Traitement pour arthrite ou bursite reactive
DK1170342T3 (da) Oplösningsmiddelholdige UV-strålehærdende belægningsstoffer
ATE322881T1 (de) Haarstyling zusammensetzung
ES2124844T3 (es) Palau'amina: un compuesto farmacologicamente activo aislado a partir de una esponja.
TH45854A3 (th) สารผสมเคลือบเล็บโพลิอะคริลและโพลิยูรีเทน
BR0016140A (pt) Composição de reticulação, composição curável, composição de emulsão curável, e, método de revestimento de um substrato
BR9915632A (pt) Benzilmaltosìdeos acilados como inibidores da proliferação de células musculares lisas
TH41747A3 (th) สารผสมเคลือบเล็บ
ATE283321T1 (de) Zweischichtlackierung aus wässrigem basislack und klarlack mit verbesserter klarlackbenetzungsgrenze
EP1319390A3 (fr) Composition capillaire fixante avec une substance cationique